| Literature DB >> 19186284 |
Abstract
Disorders of hemostasis and thrombosis are frequently encountered in the ICU setting. Understanding the relevance of laboratory findings is essential in providing appropriate therapy. Various blood products and hemostatic agents are available to assist in the control of bleeding, and several different classes of anticoagulants are now available for use. Appropriate use of these agents maximizes therapeutic effect while minimizing complications. Use of fresh frozen plasma, cryoprecipitate, and other hemostatic agents should generally be reserved for those who have active bleeding, those undergoing invasive procedures, and those at high risk for bleeding because of their underlying diagnoses or because of associated hematologic derangements.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19186284 DOI: 10.1016/j.ccm.2008.11.003
Source DB: PubMed Journal: Clin Chest Med ISSN: 0272-5231 Impact factor: 2.878